October 10, 2018

DHVI presenters at HIVR4P 2018 | Madrid, Spain

Plenary Speakers

Kevin Saunders, HIV-1 Vaccine Design for the Elicitation of V3-glycan Broadly Neutralizing Antibodies

Guido Ferrari, Influence of Vaccine Composition on Envelope Recognition by HIV-1 Vaccine induced ADCC


Satellite Speakers

Bart Haynes (Organizer), Progress in Inducing HIV Broad Neutralizing Antibodies

Todd Bradley, Host control of bnAbs

Kevin Wiehe, Overcoming roadblocks of improbable mutations in bnAb B cell lineages

Priyamvada Acharya, Structural Diversity of antibody recognition at the V3-glycan epitope

David Montefiori, bnAbs

Sallie Permar (Organizer) Immunological Mechanisms of Inducing HIV Immunity in Infants

Bart Haynes (Moderator), Immunological Mechanisms of Inducing HIV Immunity in Infants/ Immune Obstacles HIV Vaccine Development

Genevieve Fouda (Panelist) Immunological Mechanisms of Inducing HIV Immunity in Infants

Georgia Tomaras (Panelist) Immunological Mechanisms of Inducing HIV Immunity in Infants

Wilton Williams (Panelist) Immunological Mechanisms of Inducing HIV Immunity in Infants

Tony Moody (Panelist) Immunological Mechanisms of Inducing HIV Immunity in Infants

Georgia Tomaras (Speaker, Fc-mediated Antibody Functions Impacting HIV Prevention)


Oral Abstract Presentations

Maria Blasi, Therapeutic Vaccination with a Combination of IDLV-SIV-Gag and IDLV-PGT121 Results in Prolonged Virus Control in Chronically SHIV-infected Macaques 

Wilton Williams, Macaque SHIV induction of 2G12-like broadly neutralizing antibodies 

Kevin Wiehe, Targeted Selection of an Improbable HIV-1 Antibody Mutation Critical for Broadly Neutralizing Reactivity with a Designed Immunogen 

Xiaoying Shen,  V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa 

Dieter Mielke, Neutralizing and ADCC activity of anti-HIV-1 Antibodies against acute Subtype C Envs: Implications for prevention and treatment of HIV-1 Infection 

Coleen Cunningham, Safety & Pharmacokinetics of Multiple Doses of a Potent Anti-HIV Monoclonal Antibody, VRC01, in HIV-Exposed Newborns 


Oral Poster Discussion

LaTonya Williams, Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated with Correlates of HIV-1 Infection Risk 

Mattia Bonsignori Dual Maturation Pathways from the Unmutated Common Ancestor of HIV-1 Envelope Broadly Neutralizing Antibodies Overcome Glycan Barriers

Kelly Seaton, Impact of Vaccine Regimen on Vaccine Induced Antibody Durability 


Poster Presentation

Giny Fouda, Higher HIV Neutralization Breadth in Young Children Than in Chronically Infected Adults

Justin Pollara, Bridging Vaccine-induced Antibody Responses in Rabbit and Rhesus Macaque Animal Models

Ashley Nelson, Development of Neutralizing Antibody Responses in SHIV CH505-infected Adult and Infant Rhesus Macaques

David Martinez, Characterizing Env-specific Monoclonal Antibodies Isolated From U.S. and Malawian HIV-infected Non-transmitting and Transmitting Women

David Martinez, Determinants of Transplacental Transfer of Protective Maternal IgG in HIV-infected Women

Marina Tuyishme, Recognition and Elimination of HIV-1-infected Cells by ADCC-mediating mAbs for Prevention and Treatment of HIV-1 Infection

Shay Behrens, Germline-targeting and Reverse Engineering to Elicit CH235.12 Lineage bNAbs

Eliza Hompe,  Giny Fouda, Induction of Neutralizing Antibodies Against Autologous Viruses in HIV-1 Infected Pregnant Women Immunized With a gp120/160 Vaccine

Sachin Govil, David Katz Deducing Mucosal Pharmacokinetics and Pharmacodynamics for Anti-HIV Molecules From Measurements in Blood

Mehri McKellar, Providing PrEP for People Who Inject Drugs: Are Syringe Services Programs the Way to Go?

Meredith Clement, Outcomes for PrEP Users in the Southern U.S.: Persistence and STIs

Daniel Adrianzen, David Katz Modeling Probability of Infection and Its Alteration by Microbicides by Integrating HIV Transport and Infection Dynamics With Drug Transport & Action

Allan Sze, David Katz, Modeling Pharmacokinetics and Pharmacodynamics of Luminally Acting Microbicides Delivered by Vaginal Inserts: Application to Griffithsin